70 related articles for article (PubMed ID: 24704266)
1. C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB.
Zou J; Li H; Chen X; Zeng S; Ye J; Zhou C; Liu M; Zhang L; Yu N; Gan X; Zhou H; Xian Z; Chen S; Liu P
Mol Cell Endocrinol; 2014 Jun; 390(1-2):18-25. PubMed ID: 24704266
[TBL] [Abstract][Full Text] [Related]
2. Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation.
Zou J; Gan X; Zhou H; Chen X; Guo Y; Chen J; Yang X; Lei J
Mol Cell Endocrinol; 2015 Jan; 399():321-9. PubMed ID: 25450863
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein β.
Chen Y; Yu S; Zhang N; Li Y; Chen S; Chang Y; Sun G; Sun Y
Biochem Biophys Res Commun; 2017 Apr; 486(2):423-430. PubMed ID: 28315329
[TBL] [Abstract][Full Text] [Related]
4. C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis.
Ranjan P; Boss JM
Apoptosis; 2006 Oct; 11(10):1837-49. PubMed ID: 16850160
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
6. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
7. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
Liu Q; Chen Y; Auger-Messier M; Molkentin JD
Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
[TBL] [Abstract][Full Text] [Related]
8. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter.
Gorrill TS; Khalili K
Virology; 2005 Apr; 335(1):1-9. PubMed ID: 15823601
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
[TBL] [Abstract][Full Text] [Related]
10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
Cho IJ; Sung DK; Kang KW; Kim SG
Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
[TBL] [Abstract][Full Text] [Related]
11. Expression and activity of C/EBPbeta and delta are upregulated by dexamethasone in skeletal muscle.
Yang H; Mammen J; Wei W; Menconi M; Evenson A; Fareed M; Petkova V; Hasselgren PO
J Cell Physiol; 2005 Jul; 204(1):219-26. PubMed ID: 15669083
[TBL] [Abstract][Full Text] [Related]
12. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
13. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells.
El-Asmar B; Giner XC; Tremblay JJ
J Mol Endocrinol; 2009 Feb; 42(2):131-8. PubMed ID: 18996961
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity.
Flammer JR; Popova KN; Pflum MK
Biochemistry; 2006 Aug; 45(31):9615-23. PubMed ID: 16878996
[TBL] [Abstract][Full Text] [Related]
17. C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.
Boström P; Mann N; Wu J; Quintero PA; Plovie ER; Panáková D; Gupta RK; Xiao C; MacRae CA; Rosenzweig A; Spiegelman BM
Cell; 2010 Dec; 143(7):1072-83. PubMed ID: 21183071
[TBL] [Abstract][Full Text] [Related]
18. C/EBPβ (CCAAT/enhancer-binding protein β) mediates progesterone production through transcriptional regulation in co-operation with SF-1 (steroidogenic factor-1).
Mizutani T; Ju Y; Imamichi Y; Osaki T; Yazawa T; Kawabe S; Ishikane S; Matsumura T; Kanno M; Kamiki Y; Kimura K; Minamino N; Miyamoto K
Biochem J; 2014 Jun; 460(3):459-71. PubMed ID: 24635384
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
20. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
